NanJing Pharmaceutical Company Limited (600713.SS) SHH

5.27

+0.05(+0.96%)

Updated at August 19 11:29AM

Currency In CNY

Valuation

Market Cap6.46B
Enterprise Value9.4B
P/E Ratio11.71
PEG Ratio2.58
Price/Sales Ratio0.13
Price/Book Ratio0.98
Enterprise/Revenue0.27
Enterprise/EBITDA12.65

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin0.01
Operating Margin0.02

Management Effectiveness

Return On Assets0.02
Return On Equity0.09

Income Statement

Revenue53.7B
Revenue/Share41.1
Gross Profit3.37B
EBITDA1.59B
Net Income570.63M
Diluted EPS0.44

Balance Sheet

Total Cash2.65B
Total Cash/Share2.01
Total Debt10.02B
Total Debt/Equity1.43
Current Ratio1.55
Book Value Per Share6.09

Price History

52-Week Change17.98
52-Week High5.64
52-Week Low4.06
Moving Average 50 Days5.22
Moving Average 200 Days5.08

Statistics

Average Volume11.31M
Shares Outstanding1.3B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.17
Trailing Annual Dividend Yield3.24
Payout Ratio0.93
Last Split Factor2:1
Last Split DateJuly 08, 2011